Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Crop Life ScienceNSE:CLSL +2.95%55 PB Ratio is 1.75 as of Jul. 25, 2026, which is 51% above its 10-year median of 1.16. GuruFocus rates NSE:CLSL with a GF Score™ of 55/100 and a GF Value™ of ₹55.53 (Fairly Valued). The stock has 10 warning signs investors should review. Among 247 Agriculture companies, Crop Life Science ranks worse than 58.3% on this metric.
Crop Life Science Ltd stock PB Ratio (=1.75) is close to 2-year high of 1.75.
The historical rank and industry rank for Crop Life Science's PB Ratio or its related term are showing as below:
NSE:CLSL'
s PB Ratio Range Over the Past 10 Years
Min: 0.88 Med: 1.16 Max: 2.1
Current: 1.75
During the past 7 years, Crop Life Science's highest PB Ratio was 2.10. The lowest was 0.88. And the median was 1.16.
NSE:CLSL's PB Ratio is ranked worse than 58.3% of 247
companies
in the Agriculture industry
Industry Median: 1.48
vs NSE:CLSL: 1.75
During the past 12 months, Crop Life Science's average Book Value Per Share Growth Rate was 6.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 26.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 23.60% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Crop Life Science was 29.30% per year. The lowest was 10.90% per year. And the median was 27.90% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Crop Life Science PB Ratio Related Terms
Crop Life Science PB Ratio Historical Data
* Premium members only.
The historical data trend for Crop Life Science's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Agricultural Inputs subindustry, Crop Life Science's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Crop Life Science PB Ratio vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Crop Life Science's PB Ratio distribution charts can be found below:
* The bar in red indicates where Crop Life Science's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Crop Life Science (NSE:CLSL) has a PB Ratio of 1.75 as of Jul. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Crop Life Science and its competitors. This is 51% above median its historical median of 1.16. Over the past decade, Crop Life Science's PB Ratio has ranged from 0.88 to 2.10. According to the industry distribution chart, Crop Life Science ranks #144 out of 247 companies in the Agriculture industry, placing it in the top 58.3%.
Is Crop Life Science's PB Ratio too high?
Crop Life Science's current PB Ratio of 1.75 is 51% above median its 10-year median of 1.16. Over the past 10 years, this metric has ranged from a low of 0.88 to a high of 2.10. The Agriculture industry median PB Ratio is 1.48. Crop Life Science's value of 1.75 is 18.2% above this industry median. Based on the distribution chart, Crop Life Science ranks #144 out of 247 companies in the Agriculture industry, which is below the industry midpoint. Overall, Crop Life Science has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Crop Life Science's PB Ratio compare to CTVA and CF?
According to the Agriculture industry distribution chart, Crop Life Science ranks #144 out of 247 companies for PB Ratio. This places Crop Life Science in the lower half of its industry. The industry median PB Ratio is 1.48. Crop Life Science's value of 1.75 is 18.2% above this benchmark. Historically, Crop Life Science's own PB Ratio has ranged from 0.88 to 2.10 over the past decade. While the company's 10-year median is 1.16 vs. the industry median of 1.48, Crop Life Science has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for an Agriculture company?
The median PB Ratio among Agriculture companies is 1.48, based on 247 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Crop Life Science's current PB Ratio of 1.75 is 18.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Crop Life Science and its competitors. For the Agriculture industry, the median PB Ratio is 1.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Crop Life Science's current PB Ratio is 1.75, which is 51% above median its own 10-year median of 1.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crop Life Science stock overvalued right now?
Based on GuruFocus' analysis, Crop Life Science (NSE:CLSL) is currently considered Fairly Valued. The stock's GF Value™ is ₹55.53, compared to a current price of ₹61.00 — trading 9.9% above its estimated fair value. The current PB Ratio is 1.75, which is 51% above median its 10-year median of 1.16 and 18.2% above the Agriculture industry median of 1.48. Crop Life Science's overall GF Score™ is 55/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Crop Life Science (NSE:CLSL), the current PB Ratio is 1.75 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Crop Life Science (NSE:CLSL) Overvalued in 2026?
Based on GuruFocus' analysis, Crop Life Science stock appears to be overvalued.
The current stock price of ₹61.00 is trading 9.9% above its estimated GF Value™ of ₹55.53.
GuruFocus considers Crop Life Science to be Fairly Valued.
Key valuation signals for NSE:CLSL:
PB Ratio: 1.75 (51% above median its 10-year median of 1.16)
GF Value™: ₹55.53 vs. price of ₹61.00 (9.9% above fair value)
Industry Position: 18.2% above the Agriculture median (#144 of 247)
No single metric tells the full story. See the NSE:CLSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Crop Life Science Ltd manufactures and distributes a broad range of crop protection chemicals, including pesticides, insecticides, fungicides, herbicides, micro fertilizers, bio-pesticides, bio-fertilizers, plant growth regulators, and soil plant health products. The company operates its manufacturing facility in Ankleshwar, Gujarat, leveraging technology to maintain quality standards. It serves agricultural markets within India and exports to countries including Indonesia, Bangladesh, Egypt, Myanmar, Vietnam, and Sudan. Segments include Agro chemicals and Agro trade. Revenue is generated through the sale of its agricultural chemicals and related products to farmers, distributors, and agri-businesses.
55GF Score
Get the complete analysis for NSE:CLSL
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:CLSL has been successfully added to your 
